Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
9,796,183
-
Shares change
-
+2,131,977
-
Total reported value, excl. options
-
$181,524,000
-
Value change
-
+$38,987,498
-
Number of buys
-
10
-
Number of sells
-
-6
-
Price
-
$18.53
Significant Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q1 2018
23 filings reported holding MRUS - Merus N.V. - Common Shares, Euro 0.09 nominal value per share as of Q1 2018.
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,796,183 shares
of 75,893,250 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include BVF INC/IL (2,419,443 shares), Sofinnova Ventures Inc (1,961,039 shares), WELLINGTON MANAGEMENT GROUP LLP (1,427,801 shares), Novo Holdings A/S (1,410,417 shares), BAKER BROS. ADVISORS LP (1,160,014 shares), Tekla Capital Management LLC (479,150 shares), PRICE T ROWE ASSOCIATES INC /MD/ (353,886 shares), Rock Springs Capital Management LP (174,917 shares), PLATINUM INVESTMENT MANAGEMENT LTD (102,219 shares), and INTERNATIONAL BIOTECHNOLOGY TRUST PLC (75,060 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.